MenB
Meningococcal B (MenB)
Indications
Infant MenB programmes in selected EU countries; not universal across Europe.
Doses
- Dose 1: 2 months
- Dose 2: 4 months
- Dose 3: 12-month booster
Contraindications
- Anaphylaxis to previous dose
Notes
- • Paracetamol prophylaxis considered with some products in infants — see product SPC.